App-Quantinova.ai

Management of Acute Myocardial Infarction in a Patient With a Left Ventricular Assist Device

Kevin A Friede - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Duration of Dual Antiplatelet Therapy in Coronary Heart Disease: A 60,000-patient Meta-analysis of Randomised Controlled Trials

Anda Bularga - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Increase of Proplatelets and Tpo in Circulation May be a New Pathological Mechanism of Thrombosis

Mo Yang - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Clonal Hematopoiesis MutationJak2V617FAggravates NETosis and Endothelial Injury in Mouse Arteries With Erosion-like Intimas

Roberto Molinaro - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Repeated Social Defeat Exaggerates Fibrin-rich Clot Formation in Fecl3 Induced Arterial Thrombosis Mice Model by Enhancing Nets Formation

Takeshi Sugimoto - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Stress-Mediated Platelet Activation Contributes to Thrombosis: Findings From the American Heart Association Go Red for Women Strategically Focused Research Network

Tessa J Barrett - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Pre-existing Autoimmune Disease and the Risk for Cardiovascular and Non-cardiovascular Immune Mediated Adverse Events With Immune Checkpoint Inhibitors

Charlotte Lee - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Differences of Cancer Types in Hospital Mortality in Patients With Venous Thromboembolism

Okushi Yuichiro - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

CT Pulmonary Angiography Yield in Patients With an Active Malignancy: Lack of Non-invasive Screening

Olivia Lamping - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Stent Type and Outcomes in Patients With Malignancy Undergoing Percutaneous Coronary Intervention

Muhammad Mohsin Munawar - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk of Venous Thromboembolism in Hospitalized COVID-19 Patients Undergoing Thromboprophylaxis: Meta-analysis of Cohort Studies

Adeel Jamil - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Major Adverse Cardiovascular Events are Linked to Risk of Mortality in Covid-19 Patients

Chirag Patel - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Elevated Interleukin-6 Levels in COVID-19-Infected Patients Are Associated With Major Adverse Cardiac Events and/or Mortality

Nicholas Nguyen - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

ILS-969

Elevated Troponin Levels Predict Major Adverse Cardiovascular Outcomes and Mortality in COVID-19 Patients

Chirag Patel - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Rapid Liposome Mimicking SARS-CoV-2 to Elucidate Thrombosis in Endothelialized Microfluidic Chip

Angela Lai - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Hospital Readmission Among Anticoagulated Nonagenarians With Atrial Fibrillation: A Nationwide Cohort Sample

Kiro Barssoum - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Effectiveness and Safety of Switching From Warfarin to Apixaban in Advanced Chronic Kidney Disease Patients With Prevalent Atrial Fibrillation in the United States Between 2012 and 2016

Katherine Garlo - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

apixaban

Predictors of Treatment of Hospitalized Patients With Atrial Fibrillation in the US

Steven B Deitelzweig - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Outcomes Associated With Anti-coagulation versus No Anti-coagulation for Atrial Fibrillation Among Octogenarians and Nonagenarians; a Meta-analysis

Kiro Barssoum - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence and Costs of Major Atherothrombotic Vascular Events Among Patients With Peripheral Artery Disease After Revascularization

Marc P Bonaca - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

Filters

7277 Abstracts